Home > Insider Trading > Filing (0001562180-21-006116)

Filing Details

Accession Number:: 0001562180-21-006116
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-27 19:32:39
Reporting Period:: 2021-09-23

Accepted Time:: 2021-09-27 19:32:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1710072	Edgewise Therapeutics Inc.	EWTX	Pharmaceutical Preparations (2834)	821725586

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1853529	J Alan Russell	C/O Edgewise Therapeutics, Inc. 3145 Colorado Ave. Boulder CO 80303	Chief Scientific Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-09-23	21,763	$18.34	242,337	No	4	S	Direct
Common Stock	Disposition	2021-09-23	5,072	$19.42	237,265	No	4	S	Direct
Common Stock	Disposition	2021-09-24	20,100	$18.16	217,165	No	4	S	Direct
Common Stock	Disposition	2021-09-27	11,594	$17.98	205,571	No	4	S	Direct
Common Stock	Disposition	2021-09-27	17	$18.48	205,554	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021.
The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $17.93 to $18.925, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.97. to $19.96, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $17.84 to $18.45, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $17.47 to $18.45, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.